As of 8:04 PM 05/21/13 All times are local (Market data is delayed by at least 15 minutes).
Executive Profile*
Robert S. Langer Jr., Ph.D., DSc | |
| Age | Total Calculated Compensation | This person is connected to 493 board members in 49 different organizations across 60 different industries.
See Board Relationships |
| 63 | $87,500
|
Background*
Dr. Robert S. Langer, Jr., Ph.D., DSc., Bob, is a Co-Founder and Senior Partner of PureTech Ventures. Dr. Langer is a Co-Founder and Principal of Combinent Biomedical Systems, Inc. He serves as the Chairman of Scientific Advisory Board of Semprus BioSciences Corp. He is a Co-Founder of 480 Biomedical, Inc. He serves as a Scientific Advisor at TARIS BioMedical, Inc., TremRx Inc. and Algenol Biofuels Inc. He co-founded Semprus BioSciences Corp. in 2007 and served as its ... Co-Chairman of Scientific Advisory Board. He served as a Consultant at Fibrocell Science, Inc. since September 2009. He co-founded Parallel Solutions Inc., and serves as its Advisor. He co-founded Seventh Sense Biosystems, Inc. and serves as its Scientific Advisor. He co-Founded BIND Biosciences, Inc. in 2006, Pervasis Therapeutics, Inc. in 2003 and Selecta Biosciences, Inc. in 2007. He was a Founder of ModeRNA Therapeutics Inc. Dr. Langer is a Co-Founder of Momenta Pharmaceuticals Inc. and Advanced Inhalation Research, Inc. He Co-Founded Arsenal Vascular, Inc., in 2005 and Transform Pharmaceuticals, Inc. in 1999. He served as a Scientific Consultant of Echo Therapeutics, Inc. since June 2002. Dr. Langer served as a Scientific Consultant at Sontra Medical Corp. since June 2002. His research interest includes drug delivery, biotechnology, immobilized enzymes, and biomedical engineering. He Co-Founded Pulmatrix, Inc. in 2003 and serves as its Chairman of Scientific Advisory Board. He serves as the Chairman of Scientific Advisory Board at Sontra Medical Corp. He is Member of Scientific Advisory Board and Director of Moderna Therapeutics, Inc. He is a Co-founder of Echo Therapeutics, Inc. and serves as its Chairman of the Scientific Advisory Board. He serves as the Chairman of Scientific Advisory Board at BIND Biosciences, Inc. and Micell Technologies, Inc. Dr. Langer serves as the Chairman of Clinical Advisory Board at 3DM, Inc. He serves as a Co-Chair of the Scientific Advisory Board at Selecta Biosciences, Inc. He served as the Chairman of Scientific Advisory Board at TransForm Pharmaceuticals, Inc. He Co-Founded MicroCHIPS, Inc. in 1999 and serves as its Director. He has been a Director of Wyeth, LLC since January 1, 2004 and Advanced Cell Technology Inc. since October 2011. He Co-Founded T2 Biosystems, Inc. and serves as its Director. He serves as a Director of Predictive Biosciences, Inc., McGovern Institute, Fort Dodge Animal Health, Inc., Combinent Biomedical Systems, Inc., Expression Genetics, Inc., Semprus BioSciences Corp., Selecta Biosciences, Inc., Humacyte, Inc., Seventh Sense Biosystems, Inc., Micell Technologies, Inc. and BIND Biosciences, Inc. Dr. Langer serves as a Director at 480 Biomedical, Inc., Arsenal Vascular, Inc., Kala Pharmaceuticals, Inc., Boston Life Sciences, Inc., Pervasis Therapeutics Inc., and Taris Biomedical, Inc. He serves as a Director of PureTech Ventures. He serves as a Member of Strategic Advisory Board at HealthCare Royalty Partners. He has been a Member of Scientific Advisory Board at Vascular Biogenics Ltd. since October 2002. He serves as a Member of Editorial Advisory Board at Xconomy, Inc. He serves as a Member of Scientific Advisory Board at Pathogenetix, Inc. and KensaGroup, LLC. He serves as a Member of the Scientific Advisory Board at mNemoscience GmbH. He serves as a Member of Scientific Advisory Board and Director of Soft Tissue Regeneration, Inc. and Cerulean Pharma Inc. Dr. Langer has been a Member of the Scientific Advisory Board for Alnylam Biotherapeutics at Alnylam Pharmaceuticals, Inc. since June 2010. He also serves as a Member of Scientific Advisory Board at Calando Pharmaceuticals, Inc., InVivo Therapeutics Holdings Corp., and Kala Pharmaceuticals, Inc. He serves as a Member of Scientific Advisory Board at Fibrocell Science, Inc. He serves as a Member of Scientific Advisory Board at T2 Biosystems, Inc., Insert Therapeutics, Inc., Alnylam Pharmaceuticals Inc., Momenta Pharmaceuticals Inc., and VGX Pharmaceuticals, LLC. He serves as Member of Scientific and Clinical Advisory Board at Civitas Therapeutics, Inc. He serves as a Member of Advisory Board at Performance Indicator, LLC, Fate Therapeutics, Inc. and Polaris Venture Partners, Inc. Dr. Langer served as an Independent Director of Fibrocell Science, Inc. since September 2009. He served as a Director of Sontra Medical Corp. from June 2002 to December 30, 2009. He served as a Director at GMP Companies, Alkermes Inc. He served as a Member of Scientific Advisory Board at Mitsubishi Pharma Corp., Warner-Lambert, Guilford Pharmaceuticals Inc., Novomer, Inc., Sirtris Pharmaceuticals, Inc. and Eiffel Technologies Ltd. Dr. Langer served as a Member of the United States Food and Drug Administration’s Science Board from 1995 to 2002 and as its Chairman from 1999 to 2002. He served as an Outside Director of Expression Genetics, Inc. He served as a Director of Millipore Corporation from December 2009 to July 2010, LifeSync Holdings, Inc. since June 1999 and Focal, Inc. since 1996, Momenta Pharmaceuticals, Inc., from May 2001 to June 10, 2009. He served as a Director of TransForm Pharmaceuticals, Inc. He served as an Independent Director of Alseres Pharmaceuticals, Inc. from June 2000 to January 8, 2010. He served as a Member of Scientific Advisory Board at Alseres Pharmaceuticals, Inc., Telesso Technologies Limited, Warner-Lambert Company LLC, Spherics, Inc., Rosetta Genomics, Ltd., Magen BioSciences, Inc., ADViSYS, Inc., Inovio Pharmaceuticals, Inc., Stemgent, Inc. and Actar AB. He serves as a Member of NanoBiology Initiative Scientific Advisory Committee at Accelrys Inc. He serves as the Member of Nominating & Governance Committee, Member of Corporate Issues Committee and Member of Science & Technology Committee at Wyeth, LLC. Dr. Langer’s specialty is the study and development of polymers to deliver drugs, particularly genetically engineered proteins and DNA, continuously at controlled rates for prolonged periods of time. He is a renowned scientist with numerous distinguished awards, including accolades from the Institute of Medicine of the National Academy of Sciences; American Chemical Society; National Academy of Engineering, National Academy of Sciences; Gairdner Foundation; and the American Institute of Chemical Engineers. Since 1979, Dr. Langer has been a Kenneth J. Germeshausen Professor of Chemical and Biomedical Engineering at the Massachusetts Institute of Technology. He was recognized numerous times for Dr. Langer’s work relating to the chemical aspects of biomedical engineering, particularly his discoveries and advances in the area of the controlled release of macromolecules and proteins. He has written more than 950 articles and has over 600 issued or pending patents, one of which was cited as the outstanding patent in Massachusetts in 1988 and one of 20 outstanding patents in the U.S. His patents have been licensed or sublicensed to over 100 pharmaceutical, chemical, biotechnology, and medic
Corporate Headquarters*
405 Eagleview Boulevard
Exton, Pennsylvania 19341
United States
Phone: 484-713-6000
Fax: --
Board Members Memberships*
Former Director Co-Founder and Director Director Co-Founder, Chairman of Scientific Advisory Board and Director Chairman of Scientific Advisory Board and Director Co-Founder, Senior Partner, and Director Co-Founder and Director Director Director Director Co-Founder, Director and Member of Scientific Advisory Board Co-Founder, Chairman of Scientific Advisory Board and Director Co-Founder, Principal and Director Member of Scientific Advisory Board and Director Co-Founder, Chairman of Scientific Advisory Board and Director Co-Founder and Director Member of Scientific Advisory Board and Director Co-Founder, Co-Chair of the Scientific Advisory Board and Director Co-Founder, Scientific Advisor and Director Scientific Advisor and Director Director and Member of Scientific Advisory Board Director Director and Member of Scientific Advisory Board Co-Founder and Member of The Board of Directors 1996-N/A Former Director 1999-N/A Former Director 2000-2010 Former Independent Director, Member of Scientific Advisory Board, Chairman of Science & Technology Committee and Member of Nominating & Corporate Governance Committee 2001-2009 Co-founder 2002-2009 Co-Founder and Chairman of Scientific Advisory Board 2004-Present Director, Member of Nominating & Governance Committee, Member of Corporate Issues Committee and Member of Science & Technology Committee 2009-2010 Former Director, Member of Governance & Public Policy Committee and Member of Technology Committee 2009-N/A Chief Scientific Advisor and Member of Scientific Advisory Board 2011-Present Director, Chairman of Science Advisory Committee and Member of Nominating & Corporate Governance Committee
Education*
BS 1970 Cornell University PhD 1974 Massachusetts Institute of Technology Honorary Doctorate Yale University Honorary Doctorate Technion Israel Institute Of Technology Honorary Doctorate Hebrew University of Jerusalem Honorary Doctorate Universite catholique de Louvain Honorary Doctorate University of Liverpool Honorary Doctorate Northwestern University Honorary Doctorate Pennsylvania State University Honorary Doctorate Albany Medical College Honorary Doctorate Nottingham University Honorary Doctorate Uppsala Universitet
Other Affiliations*
|
Annual Compensation*
There is no Annual Compensation data available.
Stock Options*
There is no Stock Options data available.
Total Compensation*
| Total Annual Cash Compensation | $87,500 | | Total Calculated Compensation | $87,500 |
|
*Data is at least as current as the most recent Definitive Proxy.
